Purple Biotech (PPBT) Other financing activities (2019 - 2022)

Purple Biotech (PPBT) has 4 years of Other financing activities data on file, last reported at $8.0 million in Q4 2022.

• Other financing activities for Q4 2022 came in at $8.0 million, up 60.08% year-over-year; the trailing twelve-month figure through Dec 2022 was $36.3 million (up 195.79% YoY), and the FY2022 annual result was $19.8 million, up 50.57% from the prior year.
• Other financing activities slipped to $8.0 million in Q4 2022 per PPBT's latest filing, from $17.8 million in the prior quarter.
• Over five years, Other financing activities peaked at $17.8 million in Q1 2022 and troughed at -$49.6 million in Q4 2020.
• A 4-year average of -$1.0 million and a median of $5.0 million in 2019 frame the typical range for Other financing activities.
• The sharpest annual moves came in 2020 and 2022: Other financing activities slumped 1090.18% in 2020, then jumped 1269.23% in 2022.
• A 4-year view of Other financing activities shows it stood at $5.0 million in 2019, then tumbled by 1090.18% to -$49.6 million in 2020, then soared by 110.07% to $5.0 million in 2021, then jumped by 60.08% to $8.0 million in 2022.
• Business Quant data shows PPBT's Other financing activities at $8.0 million in Q4 2022, $17.8 million in Q1 2022, and $5.0 million in Q4 2021.